FDA — authorised 24 December 2008
- Marketing authorisation holder: FERRING
- Status: approved
🇺🇸 Firmagon in United States
FDA authorised Firmagon on 24 December 2008
Marketing authorisations
FDA — authorised 24 December 2008
- Application: NDA022201
- Marketing authorisation holder: FERRING
- Local brand name: FIRMAGON
- Indication: POWDER — SUBCUTANEOUS
- Status: approved
Firmagon in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Firmagon approved in United States?
Yes. FDA authorised it on 24 December 2008; FDA authorised it on 24 December 2008.
Who is the marketing authorisation holder for Firmagon in United States?
FERRING holds the US marketing authorisation.